BLLN BillionToOne, Inc.

NASDAQ

$112.39

BillionToOne, Inc. (BLLN) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.8% since its last earnings release on November 4, 2026.

BillionToOne Beat Consensus Estimates, Raises Guidance

Wednesday, November 4, 2026 · 4:05 PM ET

4th Quarter, Dec 2026

Wednesday · 4:05 PM ET

Earnings Whisper

-

vs $0.16

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $112.39

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BillionToOne, Inc.

BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.

Sector

Healthcare

Industry

Medical Labs & Research

Charts powered in part by Lightweight Charts™ by TradingView.